Search results

PURAK

This is an international study investigating wearable devices for distal arm functionality rehabilitation

STARR2

Delivering personalised care in the management of exacerbations of chronic obstructive pulmonary disease: A multi-centre randomised clinical trial.

SPECTRUM

More information coming soon

NINJA

The NINJA study is a pilot study which will assess whether a study that looks at whether nail plates should be discarded or replaced after nail bed injury in children is feasible in the NHS.

CEeDD

CEeDD: A phase I / II study to investigate the safety and feasibility of CavitationEnhanced Drug Delivery to solid tumours by co‐administration of sonosensitive particles and application of extracorporeal ultrasound

ANVIL

Anti-neutrophil cytoplasm antibody associated vasculitis treated with Interleukin-2 (ANVIL) therapy: proof of concept study.

PROMOTE IR800 IAB2M (Stage 2)

This is a single-centre study in those with high-risk prostate cancer.

OCTO-ART

This is a single centre observational study to evaluate changes in functional images (MRI, Perfusion - CT, & FDG PET) after treatment with chemoradiotherapy.

NuTide301

This is a two part, Phase 1 open label dose escalation and expansion study to assess safety, pharmacokinetics and clinical activity of NUC-3373, a nucleotide analogue, in participants with advanced solid tumours.

CYTOFLOC

MONITOR

MONITOR PsA - Multicentre ObservatioNal Initiative in Treat to target Outcomes in Psoriatic Arthritis

MACRO

This NIHR Programme aims to provide high quality evidence to establish best practice for the management of this common sinus disease. The large multi-disciplinary MACRO research team have come together to tackle the disease from many different aspects – across primary and secondary care, and from a clinical, economic and patient perspective

CHARIOT

This is a multi-centre, open label, 2 stage trial in patients with oesophageal cancer

TWO

This is a study to assess cell therapy as a treatment to prevent kidney transplant rejection. Patients will be randomly assigned to either receive standard medication after transplant or a modified regimen including the cell product.

PEP-TALK

CEDAR

CEDAR: Chemoradiation with Enadenotucirev as a radiosensitiser in locally advanced colorectal cancer

DOC-MEK

This is a multi-centre randomised trial of docetaxel with or without AZD6244 in advanced melanoma

PART

The PART study is a feasibility study comparing partial ablation (PA) and radical prostatectomy (RP) in men with intermediate risk unilateral prostate cancer. The aim of the feasibility is to determine whether or not it is possible to recruit and randomise men to a trial of this nature.

POISE

Clinical effectiveness of symptomatic therapy compared to standard step up care for the treatment of low impact psoriatic oligoarthritis: a 2 arm parallel group feasibility study

STARR2

Delivering personalised care in the management of exacerbations of chronic obstructive pulmonary disease: A multi-centre randomised clinical trial.